Loading...
XSTO
CRADb
Market cap119mUSD
Jun 16, Last price  
34.95SEK
1D
0.00%
1Q
13.29%
Jan 2017
190.04%
IPO
82.98%
Name

C Rad AB

Chart & Performance

D1W1MN
P/E
20.35
P/S
2.45
EPS
1.72
Div Yield, %
—
Shrs. gr., 5y
1.80%
Rev. gr., 5y
17.96%
Revenues
469m
+10.45%
1,291,1244,898,74914,234,44614,909,75525,775,90545,036,18453,191,61366,160,75182,653,556133,125,000190,110,000205,394,000221,628,000261,152,000301,326,000424,615,000469,000,000
Net income
57m
+59.03%
-10,722,785-10,250,579-9,838,118-42,606,182-19,388,657-20,994,730-6,298,477-21,183,842-31,209,176-10,907,00021,191,000-13,800,00014,365,00025,102,0007,479,00035,529,00056,500,000
CFO
30m
-10.43%
-10,055,732-8,726,049-5,014,115-20,426,509-13,063,389-22,856,329-16,611,834-22,951,019-44,623,107-4,020,000-9,606,00015,827,00018,447,00018,168,0009,690,00033,383,00029,900,000
Earnings
Jul 16, 2025

Profile

C-Rad AB (publ), together with its subsidiaries, develops, manufactures, and sells systems with applications in radiation therapy for the treatment of cancer worldwide. The company operates through two segments, Positioning and Imaging. Its products include Sentinel 4D CT, a laser-based optical surface scanning system; Catalyst, a 4D surface image guided radiation therapy (SIGRT) solution; Catalyst HD, an SIGRT solution on stereotactic radiation therapy for online patient tracking before and during treatment delivery; Catalyst+, an SIGRT solution for high precision patient positioning, intra-fraction motion management, and respiratory gating; and Catalyst+ HD, a solution for high precision patient positioning, intra-fraction motion management, and respiratory gating for conventional and stereotactic treatment delivery. The company's products also comprise Catalyst Tomo, an enhanced positioning solution for tomotherapy; Catalyst PT, a real-time tracking solution for particle therapy; Cyrpa laser positioning products; cAccessory, which automates the registration and validation of treatment accessories; and cPatient that automates patient identity validation without the need for contact between patients and devices. In addition, it offers installation, application training, and aftersales services. C-Rad AB (publ) was founded in 2004 and is headquartered in Uppsala, Sweden.
URL
https://c-rad.se/
IPO date
Jul 23, 2007
Employees
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
469,000
10.45%
424,615
40.92%
301,326
15.38%
Cost of revenue
146,000
141,653
100,547
Unusual Expense (Income)
NOPBT
323,000
282,962
200,779
NOPBT Margin
68.87%
66.64%
66.63%
Operating Taxes
23,300
8,397
14,006
Tax Rate
7.21%
2.97%
6.98%
NOPAT
299,700
274,565
186,773
Net income
56,500
59.03%
35,529
375.05%
7,479
-70.21%
Dividends
Dividend yield
Proceeds from repurchase of equity
(3,800)
(2,292)
1,004
BB yield
0.37%
0.16%
-0.08%
Debt
Debt current
(18,973)
Long-term debt
18,000
3,506
8,152
Deferred revenue
Other long-term liabilities
(1,000)
Net debt
(132,900)
(125,855)
(143,033)
Cash flow
Cash from operating activities
29,900
33,383
9,690
CAPEX
(4,106)
(11,222)
Cash from investing activities
(6,500)
(16,931)
(11,222)
Cash from financing activities
(7,100)
(5,690)
(2,384)
FCF
257,055
245,117
173,330
Balance
Cash
150,900
129,361
121,896
Long term investments
10,316
Excess cash
127,450
108,130
117,146
Stockholders' equity
(105,034)
(138,914)
Invested Capital
334,000
377,967
366,560
ROIC
84.19%
73.76%
50.66%
ROCE
95.93%
103.67%
88.20%
EV
Common stock shares outstanding
33,832
33,767
33,764
Price
30.00
-28.91%
42.20
10.76%
38.10
-31.60%
Market cap
1,014,970
-28.77%
1,424,965
10.77%
1,286,409
-31.94%
EV
882,070
1,299,110
1,143,376
EBITDA
323,000
291,823
210,891
EV/EBITDA
2.73
4.45
5.42
Interest
379
416
Interest/NOPBT
0.13%
0.21%